5500.1 No medical cannabis business registered under the Act shall utilize any name other than that of an individual, including a corporate or trade name, without first obtaining approval from the Board for use of the corporate or trade name.

5500.2 A medical cannabis business registered under the Act may file a written request with the Board to add an additional trade name at a location currently authorized for the sale or testing of medical cannabis. The Board, in its discretion, may approve the use of an additional trade name. Any additional trade name approved by the Board shall appear on the establishment's written registration.

5500.3 A medical cannabis business registered under the Act shall not use or display a trade name, corporate name, or sign bearing the words “pharmacy”, “apothecary”, “drug store”, or other phrase that implies that the practice of any health profession occurs on the premises.

5500.4 Any trade name requested by an applicant shall not be identical or confusingly similar to one currently used under a previously issued or existing registration.

5500.5 [REPEALED].

5500.6 [REPEALED].

SOURCE: Emergency and Third Proposed Rulemaking published at 58 DCR 3299 (April 15, 2011)[EXPIRED]; as amended by Emergency and Fourth Proposed Rulemaking published at 58 DCR 7207 (August 12, 2011)[EXPIRED]; as amended by Final Rulemaking published at 58 DCR 10128, 10198 (December 2, 2011); as amended by Final Rulemaking published at 66 DCR 10217 (August 9, 2019); as amended by Final Rulemaking published at 71 DCR 002388 (March 8, 2024); as amended by Final Rulemaking published at 73 DCR 002136 (February 20, 2026).